Scarica l'app Stockscreener
25.33
0.00%
0.00
Dopo l'orario di chiusura:
25.33
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PFE Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
Pfizer (NYSE: PFE) CEO receives 24 phantom stock units in deferred plan - Stock Titan
Target Upgraded, Pfizer Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Arbor Biotechnologies Appoints Mathew Pletcher, Ph.D., as Chief Scientific Officer - GlobeNewswire Inc.
Why Pfizer Stock Still Looks Deeply Undervalued In 2026 (NYSE:PFE) - Seeking Alpha
Thrivent Financial for Lutherans Acquires 72,504 Shares of Pfizer Inc. $PFE - MarketBeat
214,779 Shares in Pfizer Inc. $PFE Purchased by North Dakota State Investment Board - MarketBeat
Daiwa Securities Adjusts Price Target on Pfizer to $28 From $27, Maintains Neutral Rating - marketscreener.com
Pfizer Inc. (NYSE:PFE) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
FY2026 EPS Estimates for Pfizer Lowered by Erste Group Bank - MarketBeat
Pfizer Inc. stock (US7170811035): Q1 earnings beat, higher 2026 guidance and rich dividend yield dra - AD HOC NEWS
Pfizer Inc. stock (US7170811035): Q1 earnings beat, higher 2026 guidance and rich dividend yield in - AD HOC NEWS
Pfizer Faces Busy Week After Friday’s Drop - TechStock²
Pfizer Inc. Trade Ideas — LS:852009 - TradingView
Seagen Inc (Acquired) stock (US8166361055): what remains after the Pfizer takeover - AD HOC NEWS
How Pfizer Comirnaty Works and Where It Fits Today - AD HOC NEWS
John G Ullman & Associates Inc. Has $5.13 Million Stock Position in Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. $PFE Stock Holdings Boosted by Canada Post Corp Registered Pension Plan - MarketBeat
Pfizer Inc. Trade Ideas — AQUISEU:PFED - TradingView
Pfizer Inc. Trade Ideas — BX:PFEUSD - TradingView
Pfizer Inc stock (US7170811035): new trial data and pipeline focus keep attention on the pharma gian - AD HOC NEWS
Wolfe Research Says COVID Uncertainty Continues to Weigh on Pfizer (PFE) Outlook - Insider Monkey
PFE Stock Quote Price and Forecast - CNN
Assessing Pfizer (PFE) Valuation After Recent Share Price Weakness And Oncology Growth Expectations - simplywall.st
Pfizer asks for emergency use of its coronavirus vaccine - The Indian Panorama
Pfizer (NYSE:PFE) Trading Down 1.7%Here's Why - MarketBeat
Pfizer Inc. stock outperforms competitors despite losses on the day - MarketWatch
Pfizer Inc’s Next Growth Bet Is India. Investors Are Still Waiting For Proof - TechStock²
Pfizer Inc. stock (US7170811035): Q1 2026 beat, new products lift revenue while COVID business stays - AD HOC NEWS
Duavee by Pfizer, Inc - Pharmacy Times
Pfizer Refines PF-07799933 Dosing in New Phase 1 Food-Effect Study - TipRanks
Mubadala Investment dissolves share stake in Pfizer, Ford Motor, Walt Disney - marketscreener.com
Mubadala Investment Dissolves Share Stake In Pfizer, Ford Motor, Walt Disney - TradingView
Mesirow Financial Investment Management Inc. Cuts Holdings in Pfizer Inc. $PFE - MarketBeat
5 Must-Read Analyst Questions From Pfizer’s Q1 Earnings Call - Yahoo Finance
AustralianSuper Pty Ltd Acquires 671,258 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer, Inc. Stock 12‑Month Price Target Cut to $28.88, Implies 12% Upside - TradingView
PFIZER INC HUGE TARGET | PFE STOCK NEWS (jCUEslO3m8) - fathomjournal.org
Amid COVID-19 Global Pandemic, The Pfizer Foundation Helps IRC Pursue Urgent Expansion of Health Access in Humanitarian Settings - Pfizer
Pfizer’s Prazosin Site-Transfer Trial Signals Quiet but Important Supply-Chain Progress - TipRanks
Pfizer stock (US7170811035): Q1 earnings beat with revenue growth and 2026 guidance - AD HOC NEWS
Jim Cramer on Pfizer: “Pfizer Does Not Have Any Earnings Momentum” - Insider Monkey
Pfizer Just Locked In Its Next 5 Years of Growth -- Here's How - Yahoo Finance
Comirnaty COVID-19 Vaccine - AD HOC NEWS
Pfizer's Turnaround Is Taking Shape (NYSE:PFE) - Seeking Alpha
PFE Stock Declines Post Q1 Beat: Book Profits or Stay Invested? - TradingView
PFE Stock Outlook 2026: Is Pfizer a Smart Investment Right Now? - sebd.in
The Zacks Analyst Blog Meta, Pfizer, Salesforce and Smith-Midland - Yahoo Finance Singapore
Rigel Pharmaceuticals (RIGL) Is Up 20.5% After Global VEPPANU Rights Deal With Pfizer, ArvinasHas The Bull Case Changed? - Yahoo Finance
Pfizer Hemophilia Drug Win In Europe Adds Weight To Undervalued Thesis - simplywall.st
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors - BioSpace
Get to Know Our Breakthrough Fellows! - Pfizer
An Open Letter from Pfizer Chairman and CEO Albert Bourla - Pfizer
Pfizer’s 4th Latino Summit Champions Latino Representation - Pfizer
United by Our Unique and Personal Connections to Cancer - Pfizer
Chief Corporate Affairs Officer Sally Susman Discusses Political Landscape, AI at Davos - Pfizer
Top Analyst Reports for Meta, Pfizer & Salesforce - Yahoo Finance
Pfizer Options Spot-On: On May 13th, 121.75K Contracts Were Traded, With 2.64 Million Open Interest - Moomoo
Pfizer’s Hympavzi Indication Expanded in EU for Treatment of Hemophilia A or B With Inhibitors - Contract Pharma
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029? - Yahoo Finance
Pfizer stock (US7170811035): Q1 earnings beat estimates with $14.5B revenue - AD HOC NEWS
Cortisone Shots Market 2026 | Merck & Co, Pfizer, Bristol-Myers Squibb, Novartis, Pharmascience etc. - openPR.com
Pfizer wins Hympavzi label expansion in Europe (PFE:NYSE) - Seeking Alpha
European Commission approves Pfizer's Hympavzi for the treatment of adults and adolescents with hemophilia A or B with inhibitors - marketscreener.com
Pfizer Gets Expanded European OK for Hympavzi Hemophilia Drug - marketscreener.com
0.07%
0.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):